Kanger founder & MD no longer substantial shareholder.

Already said, something wrong with this company...Press release is to shore up prices or to stabilise prices when sell down. I suspect selldown will continue..in batches.

This week awaiting for BNN to announce lower BLR. Market sentiments very weak.

I think glove already no more, otherwise it will be mentioned.

"Backed by a healthy operating cash flow generated by the group’s China operations, the group has set its sights on establishing new revenue streams in Malaysia.

Recently, Kanger purchased a parcel of land measuring 2.2ha in Kuala Selangor for RM6.8 million.

The group is actively looking out for strategic opportunities with attractive prospects to invest in."

https://www.dailyexpress.com.my/news/159423/kanger-poised-to-be-top-global-producer-of-bamboo-products/

Medium cost housing, Rumah WIP types, I think

Kanger is involved only in project management services. Not as a contractor.

When Kanger announce construction ..if really got vaccine, they would at least mention la. It is one after another, they announce MOU, agreements, etc. but all also no follow through on developments. Sand, gloves, vaccine..now let's see about construction.

I also very careful. Anything above 140 is no go for me.

What is interesting is why would the Managing Director sell his shares when he know an announcement is to be made the day after? Very hard to second guess.

Remember Mosti letter. All chased and got stuck.

Project management is not complicated. All need to employ is quantity surveyor/ site manager/ clerk of works / supervisors. This is first time I heard this type of common project management also need to announce on Bursa.

"Under the terms of the agreements, Kanger will be responsible for the project management role and coordinate the remaining construction work of the six projects.

In a statement today, the ACE Market-listed company said its scope included management of sub-contractors appointed by the main contractors and handling financial matters including fulfilling payments to the sub-contractors promptly."

Read carefully..it is construction management. Not construction itself. Those figures are there to impress people. How much can charge management fees? Hahahaha.....be extra careful.
16/01/2021 7:48 AM

Construction..where is the expertise?

Wow...now Kanger from bamboo to vaccine and now to construction. Salute...

Not just ordinary director but Managing Director who is also the company founder

BUDAPEST (Reuters) - Hungary’s government said on Thursday it has reached a deal with China’s Sinopharm to buy its coronavirus vaccine, the country’s latest move to break away from Brussels as it tries to speed up inoculations to lift curbs on the economy.

Hungary would be the first EU country to accept a Chinese vaccine if approved by Hungarian authorities. Under European Union rules it would have to give an ultra-fast emergency use approval, rather than waiting for the European drug regulator EMA to give the go-ahead for the Chinese vaccine.

MD selling off his shares

Let's see if continue to go up.

More roti canai techniques..

https://www.malaymail.com/news/malaysia/2021/01/13/khairy-malaysia-to-study-sinovac-clinical-trial-data-before-approving-covid/1940067

MOU can cancel anytime. Non binding.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3120843

People tend to link Sinovax to Sinopharm...

It appears like a fishing expedition. Throw in the baits for bilis to come in.

Antivax not happy with Pharmaniaga now.

Means Pharma and Solutions competitors lor

In past cases of pythons killing humans, are the victims usually children? Or have adults been killed, too?

There's been some recorded killings of full-grown adults, but it's exceedingly rare. Usually it's kids.

What does the constricting motion of a python feel like?

A snake is made up primarily of bone and muscles ... that are extraordinarily strong. It can be startling just holding a small or medium-sized constrictor and having it just hold onto your arm to keep itself balanced.

A lot of people who hold constrictors think [the snakes] are trying to squeeze them and hurt them, but really they're just trying to hold on.

Is strangulation by a python a quick death?

It doesn't take long. Some people have had pet pythons that wrapped around their necks and cut off circulation, and they pass out and subsequently died from suffocation.

In addition to strangling their prey, do constrictors also bite?

When pythons and boas are killing prey, they use a kind of ambush technique in which they'll jump out at you and strike at you and grab you with their teeth. They'll seize the prey item with their teeth and simultaneously wrap their coil around it and squeeze. And when the victim exhales, that's the time they squeeze a little bit harder to the point where you can't really get a breath anymore.

Do pythons only strangle prey when they're hungry? Or will they do it to defend themselves as well?

When they're defending themselves, they'll either try to bite and crawl away or crawl away first. When they go through all the trouble and exert all the energy to bite something and constrict it, it's because they're hungry generally.

Do pythons typically go after prey that are of a similar size to themselves?

Snakes are opportunists. If they're hungry enough, they may go after prey that's literally too large to swallow in some cases. Snakes have been known to swallow adult male antelope with horns and all and die in the process [see video]. So they'll take whatever they can get if they're desperately hungry.

Is there anything that a person who finds themselves being constricted by a python can do to escape?

This is a horrible tragedy. I think it's a bad idea to keep large constrictors unless it's in a professional setting and you have experience with the species. It's a big responsibility, and this is the type of thing that can happen when you keep exotic animals and they're not secured.

Pekerja pembersihan terkejut jumpa ular sawa dalam guni

BALING: Disangkakan kucing, rupa-rupanya seekor ular sawa batik yang melingkar di dalam guni di tepi sangkar bahan buangan kitar semula di Taman Taman Serai Wangi, Kuala Ketil di sini semalam.

Pekerja E-Idaman cawangan Baling, Mohd. Sayuti Mohd. Daud, 41, berkata, dia dan rakan-rakannya terkejut apabila mendapati guni yang terikat kemas itu mengandungi seekor ular sawa sepanjang dua meter dengan berat hampir 20 kilogram.

“Biasanya pada pukul 10 pagi, saya dan rakan-rakan akan mengutip sampah di dalam tong-tong sampah dan sangkar kitar semula di kawasan yang telah dijadualkan.

“Saya kemudian ternampak satu guni yang diikat rapi diletakkan di luar sangkar kitar semula dan memegangnya sebelum ia bergerak-gerak,” katanya ketika ditemui di Tapak Pelupusan Sampah Kampung Pulai di sini hari ini.

Katanya, dia pada mulanya menyangkakan guni itu mengandungi anak kucing atau anjing yang dibuang.

“Kami juga terfikir kalau-kalau ada yang buang bayi, tetapi selepas buka ikatan itu, kami terkejut apabila mendapati di dalamnya ada seekor ular sawa yang besar.

“Ular sawa itu dilihat dalam keadaan kekenyangan selain agak agresif sebelum mengikat semula guni itu kerana bimbang ia terlepas keluar dan mengancam keselamatan kami atau orang awam,” ujarnya.

Tambahnya, dia seterusnya membawa reptilia itu ke tapak pelupusan sampah untuk ditunjukkan kepada majikan dan seterusnya dihantar kepada Perhilitan untuk tindakan selanjutnya,” kata Mohd Sayuti.

Ular sawa yang kekenyangan itu didapati memuntahkan seekor ayam jantan yang mungkin ditelannya sebelum ditangkap orang awam. -UTUSAN ONLINE

KUALA LUMPUR: The Yang di-Pertuan Agong, Al-Sultan Abdullah Ri'ayatuddin Al-Mustafa Billah Shah has consented to the Proclamation of Emergency Proclamation being implemented as a proactive measure to curb the symptoms of the COVID-19 pandemic.

His Majesty also consents to the period of emergency implementation until August 1, 2021 or until an earlier date if the daily COVID-19 positive case figures can be controlled and lowered effectively.

Assent is given after Prime Minister Tan Sri Muhyiddin Yassin informed his Cabinet regarding the decision and take into account consultations with His Majesty the Malay Rulers.
According to Datuk Pengelola Bijaya Diraja, Datuk Indera Ahmad Fadil Shamsuddin, the emergency consent takes into account the safety of the people and the interests of the country.

"It is also based on the current statistics of COVID-19, in particular, the constraints of logistics facilities according to the states that have been presented during the briefing session.
"Al-Sultan Abdullah also agreed with the Government's proposal for the formation of an Independent Committee which will be composed of Government and Opposition MPs as well as health and related experts.

"This Independent Committee will recommend to His Majesty the King if the implementation of this emergency can be terminated earlier," he said.

According to statistics, fifteen COVID-19 hospitals recorded the rate of bed usage for COVID-19 (non-ICU) is over 70 percent. In the Klang Valley, the usage of ICU beds for COVID-19 patients at the Kuala Lumpur Hospital and the University of Malaya Medical Center has reached 100 percent, while at the Sungai Buloh Hospital 83 percent.

The rate of use of ICU beds for COVID-19 patients in Perak, Selangor, Melaka, Terengganu and Sarawak has exceeded 70 percent.

His Majesty also called on the people to be disciplined in complying with the Standard Operating Procedures (SOP) and all orders set by the Government and relevant Government agencies during the implementation of the emergency and the Movement Control Order.

"If not curbed and controlled effectively, then it will be detrimental to the health of the people and the well-being of the country," the statement said.

In this regard, Al-Sultan Abdullah advised the people to remain calm, resilient and resilient in the face of the implementation of this emergency and the Movement Control Order for security and common interests.

Be very very careful today

PETALING JAYA: The Yang di-Pertuan Agong has declared a state of emergency to curb the spread of Covid-19.

In a statement, the Palace said the King had met with Prime Minister Muhyiddin Yassin at 5.30pm yesterday.

COVID-19 | Kanger International Berhad announced that the National Institutes of Biotechnology Malaysia (NIBM) has issued a letter stating it has no objections for the company to communicate with Sinopharm to purchase Covid-19 vaccines for private sector use in Malaysia.

This followed Kanger’s announcement on Sept 29 that the group, which is chaired by former deputy minister Nur Jazlan Mohamed, entered into a three-year collaboration agreement with Sinopharm Group Hunan Changde Medical Co Ltd.

The deal is for the distribution of Covid-19 vaccines and medical equipment in Malaysia developed by China National Pharmaceutical Group Corporation (Sinopharm).

"This is a positive step for Kanger in its efforts to commence the distribution of Sinopharm’s Covid-19 vaccines in Malaysia," Kanger said in a letter to Bursa Malaysia today.

NIBM, an agency under the Ministry of Science, Technology and Innovation Malaysia (Mosti) is the national centre for industry-based research and development in genomics, agriculture and nutraceuticals.

NIBM is effectively a consortium of three national biotechnology institutes – Malaysian Institute of Pharmaceuticals and Nutraceuticals, Agro-Biotechnology Institute Malaysia, and Malaysia Genome Institute.

"The letter from Mosti, via NIBM will strengthen Kanger’s negotiations to purchase Sinopharm’s Covid-19 vaccines for private sector use," it added.

Sinopharm, a Chinese state-owned enterprise, is the largest and oldest biotech company in China.

"Sinopharm has developed two Covid-19 vaccines which have already entered Phase 3 trials, the final stage before being approved for general use, in more than 10 countries.

"So far, nearly a million people worldwide have received Sinopharm’s Covid-19 vaccines for emergency use," Kanger said.

The investment holding company added that Sinopharm’s Covid-19 vaccines can be transported and stored at normal fridge temperatures of 2°C to 8°C.


To facilitate the safe storage, handling and distribution of the vaccines, Kanger aims to work together with Zuellig Pharma Sdn Bhd, the largest vaccine distributor in Malaysia and Asia.

"As one of the licence holders authorised by the government to handle the distribution of vaccines, Zuellig Pharma has extensive capabilities to (store in) warehouse and distribute vaccines in temperature-controlled environments," Kanger said.

The company said that this agreement would not have any effect on the issued and paid-up share capital and the substantial shareholders’ shareholdings of Kanger, as it does not involve any issuance of new shares in Kanger.

"Barring any unforeseen circumstances, any distribution agreements that arise from this venture are expected to contribute positively to the earnings and earning per share of the group in the future."

Kanger also issued a reminder that the distribution of Covid-19 vaccines is subject to and conditional upon approvals from the Health Ministry, National Pharmaceutical Regulatory Agency and other relevant authorities and/or third parties, if required.

"Kanger does not expect any material risk other than the normal business and industry risks, such as regulatory approvals of local authorities, logistics handling of the vaccines and competitors," it said.

The group added that while it may not have the prior experience to undertake the distribution of Covid-19 vaccines, it will hire an experienced team to mitigate any risks that may arise. - Mkini

KUALA LUMPUR (Sept 22): Kanger International Bhd has entered into a deal to clinch the rights to distribute a China-developed COVID-19 vaccine in Southeast Asia.

In a bourse filing, the group said that it had entered into a proxy agreement with Shenzhen Public Health Technology Co, Ltd (SZPHT). The agreement is valid until Oct 8.

Under the deal, Kanger has appointed SZPHT to procure dealership status from China National Biotec Group Company Ltd (CNBG), which is a subsidiary of China National Pharmaceutical Group Corp (Sinopharm).

“The intended dealership/distributorship is in respect of the potential COVID-19 vaccines to be produced and/or manufactured by Sinopharm and CNBG, for Kanger’s distribution of the COVID-19 vaccine (Vero Cell) in Southeast Asia,” said Kanger.

The group said SZPHT will be authorised to enter into a distribution agreement and consequently grant Kanger the right to distribute the vaccine procured from Sinopharm or CNBG.

A service fee will be negotiated between Kanger and SZPHT once the latter has successfully secured and assisted Kanger in entering into a distribution agreement with Sinopharm or CNBG.

The latest move by Kanger follows its earlier announcement that it is venturing into the rubber glove industry.

On Aug 11, the group said it was approached by Dubai-based Constellation Holdings Ltd to set up a medical examination gloves operation in Malaysia.

Constellation is the procurement agent for personal protective equipment (PPE) and medical equipment for the United Arab Emirates’ (UAE) Ministry of Health & Prevention.

Kanger had said that Constellation would acquire 49% of Kanger Glove Manufacturing Sdn Bhd (incorporated on Aug 13) for RM49,000.

The group also announced that it was acquiring some 2.24 ha of land in Kuala Selangor for RM6.8 million for a new rubber glove manufacturing plant for Kanger Glove.

Shares in Kanger finished 8.77% or 2.5 sen higher at 31 sen, valuing the group at RM568 million. The counter saw 223.8 million shares traded.

I think glove story is gone otherwise they would have mentioned in this article. It mentioned actively looking means still looking;

"Recently, Kanger purchased a parcel of land measuring 2.2ha in Kuala Selangor for RM6.8mil. The group is actively looking out for strategic opportunities with attractive prospects to invest in."

https://www.thestar.com.my/news/nation/2020/09/10/bamboo-venture-in-china#:~:text=Recently%2C%20Kanger%20purchased%20a%20parcel,attractive%20prospects%20to%20invest%20in.

Already said...Kanger only bamboo without vaccine is like June 2020 prices. Go check pricing charts la.

https://www.thestar.com.my/news/nation/2021/01/11/govt-considering-an-emergency-order-to-rein-in-pandemic

It is a bit distressing...but I think the worsening pandemic situation resulting to MCO rumors coupled with everyday political instability will erode investor sentiments and confidence. And Kanger total silence is not helping. I foresee prices to drop further...

Non stop MOUs and Agreements to stay high price.

I even sent message to Wu asking for updates. He got my message but no reply. He see me no up . Sad..

glove no info, sand no info, vaccine no info, coating no info.... wat else can jadi?

Take out equation of vaccine, it might breach 13sen. But we will see...if Kanger come out with news, that might turn things around.

If it drop really low, can still consider to keep more

It will stay cautious until Umno AGM on 31/1

Silence is golden...hope it is a golden day

UAE manufacturing Sinopharm. And we know Malaysia is keen to get involved. Which company in Malaysia will be interested?

So where will Kanger fit in this Sinopharm vaccine game?

https://www.youtube.com/watch?reload=9&v=Bk2XH_tTMqE

Today Umno decides...

Yes, it is Kanger I am concerned about, not Sinopharm. It depends on how concrete the paperwork is.

Solutions & MyEG all have binding distributorship agreements in place, unlike Kanger which still have not formalise any distributorships. The MOU which they signed as it is "Memorandum of Understanding", a non binding document outlining the intentions only.

Like I say, I am not worried about Sinopharm. I will take whenever they are available. I need to travel frequently.

Many of my Muslim friends is not just against non halal vaccines but rejected vaccines altogether, also for religious reasons.

Also announced Government decided only 18+ and above be vaccinated. That means got lots of excess.

Illegal workers won't want to spend the money or be vaccinated for fear of being tracked and deported.